MY139206A - Pharmaceuticals compositions comprising mycophenolic acid or mycophenolate salt - Google Patents

Pharmaceuticals compositions comprising mycophenolic acid or mycophenolate salt

Info

Publication number
MY139206A
MY139206A MYPI20023865A MYPI20023865A MY139206A MY 139206 A MY139206 A MY 139206A MY PI20023865 A MYPI20023865 A MY PI20023865A MY PI20023865 A MYPI20023865 A MY PI20023865A MY 139206 A MY139206 A MY 139206A
Authority
MY
Malaysia
Prior art keywords
mycophenolic acid
mycophenolate salt
pharmaceuticals compositions
mycophenolate
salt
Prior art date
Application number
MYPI20023865A
Other languages
English (en)
Inventor
Jurgen Dederichs
Thomas Rigassi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9924043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY139206(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MY139206A publication Critical patent/MY139206A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI20023865A 2001-10-17 2002-10-16 Pharmaceuticals compositions comprising mycophenolic acid or mycophenolate salt MY139206A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0124953.1A GB0124953D0 (en) 2001-10-17 2001-10-17 Organic Compounds

Publications (1)

Publication Number Publication Date
MY139206A true MY139206A (en) 2009-08-28

Family

ID=9924043

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20023865A MY139206A (en) 2001-10-17 2002-10-16 Pharmaceuticals compositions comprising mycophenolic acid or mycophenolate salt

Country Status (31)

Country Link
US (3) US20050013859A1 (enExample)
EP (1) EP1438040B2 (enExample)
JP (2) JP2005508959A (enExample)
KR (1) KR100671367B1 (enExample)
CN (1) CN1310640C (enExample)
AR (2) AR036813A1 (enExample)
AT (1) ATE374023T1 (enExample)
AU (1) AU2002338897B2 (enExample)
BR (1) BR0213355A (enExample)
CA (1) CA2460574A1 (enExample)
CO (1) CO5390076A1 (enExample)
CY (1) CY1107841T1 (enExample)
DE (1) DE60222687T3 (enExample)
DK (1) DK1438040T4 (enExample)
EC (2) ECSP024342A (enExample)
ES (1) ES2292819T5 (enExample)
GB (1) GB0124953D0 (enExample)
HU (1) HU231114B1 (enExample)
IL (2) IL160968A0 (enExample)
MX (1) MXPA04003636A (enExample)
MY (1) MY139206A (enExample)
NO (1) NO341804B1 (enExample)
NZ (1) NZ532280A (enExample)
PE (1) PE20030476A1 (enExample)
PL (2) PL234541B1 (enExample)
PT (1) PT1438040E (enExample)
RU (2) RU2338528C2 (enExample)
SI (1) SI1438040T2 (enExample)
TW (1) TWI333861B (enExample)
WO (1) WO2003032978A1 (enExample)
ZA (1) ZA200401977B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
CN101052631A (zh) * 2004-07-20 2007-10-10 特瓦药厂私人有限公司 结晶霉酚酸钠
GB0419355D0 (en) * 2004-08-31 2004-09-29 Novartis Ag Organic compounds
WO2006086498A2 (en) * 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors
WO2006086500A2 (en) * 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Compositions and methods for treating vascular, autoimmune and inflammatory diseases
EP1940388A2 (en) * 2005-09-30 2008-07-09 Novartis AG Dpp iv inhibtor for use in the treatment of autoimmune diseases and graft rejection
EP1965760B1 (de) 2005-12-21 2013-02-27 Basf Se Feinteiliges quervernetztes polyvinylpyrrolidon als tablettensprengmittel
CA2640283A1 (en) * 2006-02-13 2007-08-23 Novartis Ag High dosage of mycophenolic acid (mpa)
WO2008148742A2 (de) 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
US8568780B2 (en) 2007-06-06 2013-10-29 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
MX2010001711A (es) * 2007-08-13 2010-03-11 Panacea Biotec Ltd Composiciones de liberacion extendida que comprenden micofenolato sodico y procedimientos de las mismas.
AU2009220779A1 (en) * 2008-03-05 2009-09-11 Panacea Biotec Limited Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
US20100010082A1 (en) * 2008-07-09 2010-01-14 Aspreva International Ltd. Formulations for treating eye disorders
US20110086102A1 (en) * 2009-10-13 2011-04-14 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011046546A1 (en) * 2009-10-13 2011-04-21 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011051967A2 (en) * 2009-10-23 2011-05-05 Alkem Laboratories Ltd Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
GB201100786D0 (en) 2011-01-18 2011-03-02 Ems Sa Pharmaceutical compositions of immunosuppressants
CN102793658A (zh) * 2012-08-23 2012-11-28 无锡福祈制药有限公司 一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片
CN103845323B (zh) * 2012-11-30 2018-02-02 重庆华邦制药有限公司 麦考酚酸及其盐肠溶制剂和制备方法
WO2014167442A1 (en) 2013-03-26 2014-10-16 Wockhardt Limited Pharmaceutical compositions comprising mycophenolic acid or salts thereof
CN106727403A (zh) * 2017-01-03 2017-05-31 无锡福祈制药有限公司 一种麦考酚钠肠溶片及其制备方法
JP7385474B2 (ja) * 2017-03-13 2023-11-22 オカヴァ ファーマシューティカルズ， インコーポレイテッド 非ヒト哺乳動物にミコフェノール酸活性剤を送達すための方法および組成物
CA3102412A1 (en) 2018-06-06 2019-12-12 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
WO2019238647A1 (en) * 2018-06-14 2019-12-19 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
RU2723255C2 (ru) * 2018-11-14 2020-06-09 Общество с ограниченной ответственностью "Изварино Фарма" Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
EP4438037A1 (en) * 2021-01-28 2024-10-02 Priothera SAS Methods of treatment with s1p receptor modulators
EP4346790A4 (en) * 2021-05-26 2025-04-16 The Texas A&M University System Biodegradable mucoadhesive pharmaceutical formulations and methods thereof
CN117442580B (zh) * 2023-12-21 2024-04-05 泊诺(天津)创新医药研究有限公司 一种高生物利用度麦考酚钠肠溶片及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157100A (en) † 1966-09-27 1969-07-02 Ici Ltd Pharmaceutical Compositions
GB1157099A (en) * 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1203328A (en) * 1968-06-04 1970-08-26 Ici Ltd Pharmaceutical compositions
US3705946A (en) * 1971-05-25 1972-12-12 Lilly Co Eli Method of treating hyperuricemia
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
JPS56127093A (en) * 1980-03-10 1981-10-05 Ajinomoto Co Inc Preparation of mycophenolic acid
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US5177072A (en) * 1987-01-30 1993-01-05 Syntex (U.S.A.) Inc. Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
AU3178293A (en) * 1992-11-24 1994-06-22 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
WO1994012184A1 (en) * 1992-11-24 1994-06-09 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
DK0686034T3 (da) * 1993-02-26 2001-08-27 Procter & Gamble Bisacodyl-doseringsform
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
ES2248793T3 (es) * 1993-10-01 2006-03-16 Roche Palo Alto Llc Suspensiones orales de alta dosis de mofetil micofenolato.
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
WO2000067773A2 (en) * 1999-05-10 2000-11-16 Novartis Ag Combinations of immunosupressive agents for the treatment or prevention of graft rejections
HUP9903226A2 (en) * 1999-09-23 2002-08-28 Gyogyszerki Process for producing mycophenolic acid and derivatives thereof
EP1259631B1 (en) * 2000-02-29 2005-10-12 Biocon Limited Manufacture and purification of mycophenolic acid
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
US20050013859A1 (en) 2005-01-20
DE60222687T3 (de) 2020-03-05
TWI333861B (en) 2010-12-01
US20120237601A1 (en) 2012-09-20
ECSP024341A (es) 2003-12-01
ZA200401977B (en) 2006-05-31
MXPA04003636A (es) 2004-07-27
ATE374023T1 (de) 2007-10-15
BR0213355A (pt) 2006-05-23
KR20050037409A (ko) 2005-04-21
NO341804B1 (no) 2018-01-22
CN1564684A (zh) 2005-01-12
IL160968A0 (en) 2004-08-31
AU2002338897B2 (en) 2006-10-19
SI1438040T2 (sl) 2020-02-28
GB0124953D0 (en) 2001-12-05
EP1438040B1 (en) 2007-09-26
PT1438040E (pt) 2008-01-02
PL415001A1 (pl) 2016-02-29
RU2007130786A (ru) 2009-02-20
PL367738A1 (en) 2005-03-07
DK1438040T4 (da) 2020-01-27
PL234541B1 (pl) 2020-03-31
SI1438040T1 (sl) 2008-04-30
JP2009137996A (ja) 2009-06-25
EP1438040B2 (en) 2019-10-16
NO20041785L (no) 2004-05-03
DE60222687T2 (de) 2008-07-17
US20100210717A1 (en) 2010-08-19
ES2292819T3 (es) 2008-03-16
CY1107841T1 (el) 2013-06-19
HU231114B1 (hu) 2020-09-28
EP1438040A1 (en) 2004-07-21
CO5390076A1 (es) 2004-04-30
JP2005508959A (ja) 2005-04-07
HUP0600451A2 (en) 2006-09-28
IL160968A (en) 2016-04-21
DE60222687D1 (de) 2007-11-08
DK1438040T3 (da) 2008-02-04
PE20030476A1 (es) 2003-07-30
RU2381026C2 (ru) 2010-02-10
AR085778A2 (es) 2013-10-30
HK1067861A1 (en) 2005-04-22
ES2292819T5 (es) 2020-05-29
CN1310640C (zh) 2007-04-18
CA2460574A1 (en) 2003-04-24
NZ532280A (en) 2007-05-31
AR036813A1 (es) 2004-10-06
RU2338528C2 (ru) 2008-11-20
WO2003032978A1 (en) 2003-04-24
ECSP024342A (es) 2003-03-10
RU2004115332A (ru) 2005-04-20
KR100671367B1 (ko) 2007-01-19

Similar Documents

Publication Publication Date Title
MY139206A (en) Pharmaceuticals compositions comprising mycophenolic acid or mycophenolate salt
ZA200203867B (en) alpha-Amino acids compounds, a process for their preparation and pharmaceutical compositions containing them.
TWI268278B (en) 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
AP2003002916A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
MY134136A (en) Novel compounds comprising jak3 kinase inhibitors
ZA200202525B (en) α-amino acid sulphonyl compounds, a process for their preparation and pharmaceutical compositions containing them.
MXPA02007080A (es) Compuestos novedosos que tienen actividades hipolidemicas e hipocolesterolemicas, proceso para su preparacion y composiciones farmaceuticas que los contienen.
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
EA200400455A1 (ru) Способ приготовления быстрорастворимой дозировочной формы
MXPA02004119A (es) Nuevos ciclopropanos como antagonistas de cgrp, medicamentos que contienen estos compuestos y metodo para obtencion de los mismos.
TW200716605A (en) 2,6-quinolinyl derivatives, processes for preparing them and their uses
MXPA03007635A (es) P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
ZA200309514B (en) Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives.
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
ZA200108404B (en) Cyclobutenedione compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200302159B (en) New compounds derived from quinazoline, a process for their preparation and pharmaceutical compositions containing them.
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MXPA03008211A (es) Predispersiones, proceso para su preparacion, composiciones para las mismas, proceso para la preparacion de tales composiciones..
ZA200202030B (en) Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them.
AP2001002369A0 (en) Pharmaceutical complex.
ZA200205598B (en) Benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200202220B (en) Indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them.
MXPA03005965A (es) Composicion farmaceutica que contiene citalopram.
AU2002223617A1 (en) Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
ZA200203086B (en) Pyrimidin-4-one compounds, a process for their preparation and pharmaceutical compositions containing them.